Read Trending Stories
- » Are Facebook Losses Bigger Than Initially Thought?
- » Consumer Business Recap: Toyota Needs Emerging Markets, Wal-Mart's Express Update
- » Consumer Biz Recap: Talbots CRASHES HARD, Time Warner Eyes Sports Website
- » Your Cheat Sheet to Apple's Week of Stock Moving News
- » AOL and 2 Media Titans Making Waves
Today's Trending Stocks
Click a Company to Research Now:
- Bank of America (BAC)
- Apple . (AAPL)
- Facebook (FB)
- AT&T (T)
- Nokia (NOK)
- Delcath Systems (DCTH)
- Mentor Graphics Corp (MENT)
- Complete Genomics (GNOM)
Sanofi’s (NYSE:SNY) fourth quarter income of Genzyme and emerging markets offsets the death of patents and the effect of European Union rigor. Sanofi’s earnings per share will fall 12%-15% due to patent loss of Plavix and Avapro, but predicts 5% annual sales growth and faster earnings per share growth after that to 2015.
Investing Insights: Neurocrine Biosciences Inc. Earnings: Weak Revenue and Net Income.
GlaxoSmithKline (NYSE:GSK) says it’s been deporting large sums of cash out of eurozone countries for months, converting euros back daily to the United Kingdom in sterling, out of fear the debt crisis may take a turn for the worse. “You don’t have money in banks you’re nervous about,” CEO Sir Andrew Witty remarked at the company’s annual presentation in London.
Amgen’s (NASDAQ:AMGN) Xgeva, which is used for prostate cancer bone metastasis prevention, according to a Bloomberg report, has been limited in use by a 12-1 vote from the Food and Drug Administration.
Don’t Miss: Laboratory Corp. of America Holdings Fourth Quarter Earnings Sneak Peek.
Johnson & Johnson (NYSE:JNJ), Merck & Co. Inc. (NYSE:MRK), Pfizer Inc. (NYSE:PFE), AstraZeneca Plc. (NYSE:AZN) and Eisai Co., Ltd. (ESALY.PK) are amongst the big pharmaceutical companies that produce stomach-acid medications the Food and Drug Administration warns can cause a dangerous bacterial infection. Numerours drugs include the at-risk PPI medication with Protonix, AcipHex, and Nexium being some of the larger names.
Cerner’s (NASDAQ:CERN) strong fourth quarter is providing assistance to other healthcare IT names. Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX), Merge Healthcare, Inc. (NASDAQ:MRGE), Computer Programs & Systems, Inc. (NASDAQ:CPSI), and Quality Systems, Inc. (NASDAQ:QSII) are all going up meanwhile, and they might also be getting a boost from a UBS, Inc. (NYSE:UBS) note claiming management struck a bullish tone at a recent conference.
Earnings Report: Health Management Associates Inc. Fourth Quarter Earnings Sneak Peek.
To contact the reporter on this story: at staff.writers@wallstcheatsheet.com
To contact the editor responsible for this story: Damien Hoffman at editors@wallstcheatsheet.com
Get Your FREE Special Report: 4 Things You Must Know About the US Economy Now!
Do You Want More Profits? Wall St. Cheat Sheet Premium newsletter subscribers have been crushing the markets with winning stock picks.
Click here now for your FREE trial to our acclaimed flagship newsletter:
